DOCSLIB.ORG

Medication Therapeutic Classes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medication Therapeutic Classes Medication Therapeutic Classes 000000 PLACEBO 100000 R E S E R V E D 010000 PENICILLINS 110000 ANTIFUNGALS 011000 PENICILLIN G 114000 IMIDAZOLE-RELATED ANTIFUNGALS 012000 AMPICILLINS 114040 IMIDAZOLES 013000 PENICILLINASE-RESISTANT 114070 TRIAZOLES 014000 EXTENDED SPECTRUM 115000 ANTIFUNGAL - GLUCAN SYNTHESIS INHIBITORS (ECHINOCANDINS) 015000 AMIDINOPENICILLIN 120000 ANTIVIRAL 019900 PENICILLIN COMBINATIONS 121000 ANTIRETROVIRALS 019905 PENICILLIN-AMINOGLYCOSIDE COMBINATIONS 121025 ANTIRETROVIRALS - FUSION INHIBITORS 019940 PENICILLIN-NSAIA COMBINATIONS 121045 ANTIRETROVIRALS - PROTEASE INHIBITORS 020000 CEPHALOSPORINS 121050 ANTIRETROVIRALS - RTI-NUCLEOSIDE ANALOGUES-PURINES 021000 CEPHALOSPORINS - 1ST GENERATION 121060 ANTIRETROVIRALS - RTI-NUCLEOSIDE ANALOGUES-PYRIMIDINES 022000 CEPHALOSPORINS - 2ND GENERATION 121080 ANTIRETROVIRALS - RTI-NUCLEOSIDE ANALOGUES-THYMIDINES 023000 CEPHALOSPORINS - 3RD GENERATION 121085 ANTIRETROVIRALS - RTI-NUCLEOTIDE ANALOGUES 024000 CEPHALOSPORINS - 4TH GENERATION 121090 ANTIRETROVIRALS - RTI-NON-NUCLEOSIDE ANALOGUES 029900 CEPHALOSPORIN COMBINATIONS 121099 ANTIRETROVIRAL COMBINATIONS 030000 MACROLIDE ANTIBIOTICS 122000 CMV AGENTS 031000 ERYTHROMYCINS 123500 HEPATITIS AGENTS 031099 ERYTHROMYCIN COMBINATIONS 123520 HEPATITIS B AGENTS 032000 TROLEANDOMYCIN 123530 HEPATITIS C AGENTS 033000 LINCOMYCINS 124000 HERPES AGENTS 034000 AZITHROMYCIN 124050 HERPES AGENTS - PURINE ANALOGUES 035000 CLARITHROMYCIN 124080 HERPES AGENTS - THYMIDINE ANALOGUES 035200 DIRITHROMYCIN 125000 INFLUENZA AGENTS 035500 MIOCAMYCIN 125040 NEURAMINIDASE INHIBITORS 035700 ROXITHROMYCIN 126000 RESPIRATORY SYNCYTIAL VIRUS (RSV) AGENTS 036000 SPIRAMYCIN 126040 RSV AGENTS - NUCLEOSIDE ANALOGUES 040000 TETRACYCLINES 127000 MISC. ANTIVIRALS 049900 TETRACYCLINE COMBINATIONS 129900 ANTIVIRAL COMBINATIONS 049940 TETRACYCLINE-NSAIA COMBINATIONS 129950 NUCLEOSIDE ANALOG & INTERFERON COMBINATIONS 050000 FLUOROQUINOLONES 130000 ANTIMALARIAL 060000 R E S E R V E D 139900 ANTIMALARIAL COMBINATIONS 070000 AMINOGLYCOSIDES 140000 AMEBICIDES 080000 SULFONAMIDES 149900 AMEBICIDE COMBINATIONS 089900 SULFA COMBINATIONS 150000 ANTHELMINTIC 090000 ANTIMYCOBACTERIAL AGENTS 159900 ANTHELMINTIC COMBINATIONS 099900 ANTI TB COMBINATIONS 160000 MISC. ANTI-INFECTIVES 01/19/06 11:58 am Page 1 of 20 THERCLAS Medication Therapeutic Classes 161000 POLYMYXINS 211500 ANTIESTROGENS 161500 CARBAPENEMS 211520 AROMATASE INHIBITORS 162000 CHLORAMPHENICALS 212000 ANTINEOPLASTIC ANTIBIOTICS 162100 KETOLIDES 212500 ANTINEOPLASTIC ENZYMES 162200 LINCOSAMIDES 213000 ANTIMETABOLITES 162300 OXAZOLIDINONES 213300 ANTINEOPLASTIC - ANGIOGENESIS INHIBITORS 162500 STREPTOGRAMINS 213350 VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS 162599 STREPTOGRAMIN COMBINATIONS 213500 ANTINEOPLASTIC - ANTIBODIES 162700 CYCLIC LIPOPEPTIDES 213530 ANTINEOPLASTIC - MONOCLONAL ANTIBODIES 163000 LEPROSTATICS 213550 ANTINEOPLASTIC ANTIBODY-DRUG COMPLEXES 164000 ANTIPROTOZOAL AGENTS 213580 ANTINEOPLASTIC -ANTIBODY FOR RADIOPHARMACEUTICAL THERAPY 164030 FOLATE ANTAGONISTS 214000 ANTINEOPLASTIC - HORMONAL AGENTS 165000 ANTI-INFECTIVE ADJUVANTS 214020 ANDROGENS-ANTINEOPLASTIC 166000 SEPSIS SYNDROME AGENTS 214022 ANTIADRENALS 166040 SEPSIS SYNDROME AGENTS - NON-ANTIBIOTIC 214024 ANTIANDROGENS 169900 MISC. ANTI-INFECTIVE COMBINATIONS 214026 ANTIESTROGENS 170000 VACCINES 214028 AROMATASE INHIBITORS 171000 VIRAL VACCINES 214030 ESTROGENS-ANTINEOPLASTIC 171099 VIRAL VACCINE COMBINATIONS 214035 ESTROGEN RECEPTOR ANTAGONIST 172000 BACTERIAL VACCINES 214040 PROGESTINS-ANTINEOPLASTIC 179900 MIXED VACCINE COMBINATIONS 214050 LHRH ANALOGS 180000 TOXOIDS 214055 GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONIST 189900 TOXOID COMBINATIONS 214500 ANTINEOPLASTIC - IMMUNOMODULATORS 190000 PASSIVE IMMUNIZING AGENTS 215000 MITOTIC INHIBITORS 191000 IMMUNE SERUMS 215300 ANTINEOPLASTIC ENZYME INHIBITORS 192000 ANTITOXINS-ANTIVENINS 215340 ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS 195000 MONOCLONAL ANTIBODIES 215360 ANTINEOPLASTIC - PROTEASOME INHIBITORS 195020 ANTIVIRAL MONOCLONAL ANTIBODIES 215500 TOPOISOMERASE I INHIBITORS 199900 ANTISERA COMBINATIONS 216000 ANTINEOPLASTIC RADIOPHARMACEUTICALS 200000 BIOLOGICALS MISC 217000 ANTINEOPLASTICS MISC. 201000 ALLERGENIC EXTRACTS 217030 ANTINEOPLASTICS - INTERLEUKINS 201099 MIXED ALLERGENIC EXTRACTS 217070 ANTINEOPLASTICS - PHOTOACTIVATED AGENTS 210000 ANTINEOPLASTICS 217080 RETINOIDS 211000 ALKYLATING AGENTS 217082 SELECTIVE RETINOID X RECEPTOR AGONISTS 211010 NITROGEN MUSTARDS 217500 CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS 211020 NITROSOUREAS 217540 CARDIAC PROTECTIVE AGENTS 211040 IMIDAZOTETRAZINES 217550 FOLIC ACID ANTAGONISTS RESCUE AGENTS 01/19/06 11:58 am Page 2 of 20 THERCLAS Medication Therapeutic Classes 217580 URINARY TRACT PROTECTIVE AGENTS 271010 MIXED INSULIN 217600 CHEMOTHERAPY ADJUVANTS 271020 BEEF INSULIN 217640 CHEMOTHERAPY ADJUVANTS - HYPERURICEMIA AGENTS 271030 PORK INSULIN 218000 INVESTIGATIONAL-ANTINEOPLASTIC 271040 HUMAN INSULIN 219900 ANTINEOPLASTIC COMBINATIONS 272000 SULFONYLUREAS 220000 CORTICOSTEROIDS 272099 SULFONYLUREA COMBINATIONS 221000 GLUCOCORTICOSTEROIDS 272300 ANTIDIABETIC - AMINO ACID DERIVATIVES 221099 STEROID COMBINATIONS 272340 ANTIDIABETIC - D-PHENYLALANINE DERIVATIVES 222000 MINERALOCORTICOIDS 272500 BIGUANIDES 230000 ANDROGEN-ANABOLIC 272800 MEGLITINIDE ANALOGUES 231000 ANDROGENS 273000 DIABETIC OTHER 231099 ANDROGEN COMBINATIONS 273099 DIABETIC OTHER - COMBINATIONS 232000 ANABOLIC STEROIDS 274000 ALDOSE REDUCTASE INHIBITORS 240000 ESTROGENS 275000 ALPHA-GLUCOSIDASE INHIBITORS 249900 ESTROGEN COMBINATIONS 276000 INSULIN SENSITIZING AGENTS 249910 ESTROGEN & ANDROGEN 276070 THIAZOLIDINEDIONES 249915 ESTROGEN & ANTIANDROGEN 279900 ANTIDIABETIC COMBINATIONS 249920 ESTROGEN & ANTIANXIETY AGENT 279970 SULFONYLUREA-BIGUANIDE COMBINATIONS 249930 ESTROGEN & PROGESTIN 279980 THIAZOLIDINEDIONE-BIGUANIDE COMBINATIONS 249940 ESTROGEN-ANDROGEN-PROGESTIN 280000 THYROID 250000 CONTRACEPTIVES 281000 THYROID HORMONES 251000 PROGESTIN OC'S 281099 THYROID COMBINATIONS 251500 PROGESTIN CONTRACEPTIVES - INJECTABLE 283000 ANTITHYROID AGENTS 252000 PROGESTIN IUD 290000 OXYTOCICS 253000 PROGESTIN IMPLANTS 292000 ABORTIFACIENTS/AGENTS FOR CERVICAL RIPENING 254000 EMERGENCY CONTRACEPTIVES 292010 ABORTIFACIENTS/CERVICAL RIPENING - PROSTAGLANDINS 254099 EMERGENCY CONTRACEPTIVE COMBINATIONS 299900 OXYTOCIC COMBINATIONS 259600 COMBINATION CONTRACEPTIVES - TRANSDERMAL 299910 OXYTOCIC MIXTURES 259700 COMBINATION CONTRACEPTIVES - VAGINAL 300000 MISC. ENDOCRINE 259800 COMBINATION CONTRACEPTIVES - INJECTABLE 300200 ADRENAL STEROID INHIBITORS 259900 COMBINATIONS OC'S 300400 CALCIUM REGULATORS 259910 BIPHASIC OC'S 300420 BISPHOSPHONATES 259920 TRIPHASIC OC'S 300430 CALCITONINS 259930 EXTENDED-CYCLE OC'S 300440 PARATHYROID HORMONE AND DERIVATIVES 260000 PROGESTINS 300450 MISC. CALCIUM REGULATORS 270000 ANTIDIABETIC 300500 HORMONE RECEPTOR MODULATORS 271000 INSULIN 300530 SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS) 01/19/06 11:58 am Page 3 of 20 THERCLAS Medication Therapeutic Classes 300600 FERTILITY REGULATORS 321500 POTASSIUM-CHANNEL ACTIVATORS 300620 OVULATION STIMULANTS-GONADOTROPINS 322000 ANTIANGINALS-OTHER 300660 OVULATION STIMULANTS-SYNTHETIC 329900 ANTIANGINAL COMBINATIONS 300699 FERTILITY REGULATOR COMBINATIONS 329910 NITRATE COMBINATIONS 300700 LUTEINIZING HORMONE RELEASING-HORMONE (LHRH/GNRH) 330000 BETA BLOCKERS 300800 LHRH/GNRH AGONIST ANALOG PITUITARY SUPPRESSANTS 331000 BETA BLOCKERS NON-SELECTIVE 300900 GNRH/LHRH ANTAGONISTS 332000 BETA BLOCKERS CARDIO-SELECTIVE 301000 GROWTH HORMONE 333000 ALPHA-BETA BLOCKERS 301500 GROWTH HORMONE RELEASING HORMONE (GHRH) 340000 CALCIUM BLOCKERS 301700 SOMATOSTATIC AGENTS 350000 ANTIARRHYTHMIC 301800 GROWTH HORMONE RECEPTOR ANTAGONIST 350500 ANTIARRHYTHMICS TYPE I - NONSPECIFIC 302000 POSTERIOR PITUITARY 351000 ANTIARRHYTHMICS TYPE I-A 302010 VASOPRESSIN 352000 ANTIARRHYTHMICS TYPE I-B 303000 CORTICOTROPIN 353000 ANTIARRHYTHMICS TYPE I-C 304000 PROLACTIN INHIBITORS 354000 ANTIARRHYTHMICS TYPE III 304020 DOPAMINE RECEPTOR AGONISTS 355000 MISC. ANTIARRHYTHMIC 305000 PROGESTERONE RECEPTOR ANTAGONISTS 360000 ANTIHYPERTENSIVE 305020 ABORTIFACIENT - PROGESTERONE RECEPTOR ANTAGONISTS 361000 ACE INHIBITORS 306000 MENOPAUSAL SYMPTOMS SUPPRESSANT 361500 ANGIOTENSIN II RECEPTOR ANTAGONIST 306040 HORMONAL AGENTS 362000 ANTIADRENERGIC ANTIHYPERTENSIVES 308000 UTERINE RELAXANTS 362010 ANTIADRENERGICS - CENTRALLY ACTING 309000 METABOLIC MODIFIERS 362020 ANTIADRENERGICS - PERIPHERALLY ACTING 309030 CARNITINE REPLENISHER - AGENTS 362030 RESERPINE 309036 FABRY DISEASE - AGENTS 362500 SELECTIVE ALDOSTERONE RECEPTOR ANTAGONISTS (SARAS) 309040 HEREDITARY TYROSINEMIA TYPE 1 (HT-1) TREATMENT - AGENTS 363000 AGENTS FOR PHEOCHROMOCYTOMA 309045 HOMOCYSTINURIA TREATMENT - AGENTS 364000 VASODILATORS 309050 HYPERPARATHYROID TREATMENT - VITAMIN D ANALOGS 364010 FLUOROQUINOLONE VASODILATORS 309052 CALCIMIMETIC AGENTS 364020 DOPAMINE D1 RECEPTOR AGONISTS 309065 MUCOPOLYSACCHARIDOSIS I (MPS I) - AGENTS 365000 ANTIHYPERTENSIVE - MAOIS 309080 UREA CYCLE DISORDER - AGENTS 366000 MISC. ANTIHYPERTENSIVES 309900 MISC. ENDOCRINE COMBINATIONS 369900 ANTIHYPERTENSIVE COMBINATIONS 310000 CARDIOTONICS 369910 RESERPINE COMBINATIONS 311000 PHOSPHODIESTERASE INHIBITORS 369915 ACE INHIBITORS & CALCIUM BLOCKERS 312000 CARDIAC GLYCOSIDES 369918 ACE INHIBITORS & THIAZIDE/THIAZIDE-LIKE 318000 CARDIOPROTECTANTS 369920 BETA BLOCKER & DIURETIC COMBINATIONS 320000 ANTIANGINAL AGENTS 369925 BETA BLOCKER & CALCIUM BLOCKER COMBINATIONS 321000 NITRATES 369940
Load more

Recommended publications
  • I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St
    2014;22(1):13-18 TCP Translational and Clinical Pharmacology http://dx.doi.org/10.12793/tcp.2014.22.1.13 Clinical Pharmacology Review for Primary Health Care Providers: I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 137-701, Korea *Correspondence: S. Han; Tel: +82-2-2258-7326, Fax: +82-2-2258-7876, E-mail: [email protected] Received 31 May 2014 Primary health care providers play a critical role in maintaining public health, and the appropri- Accepted 31 May 2014 ate use of pharmaceutical products is one of the major parts of their practice. This series of articles, pISSN: 2289-0882 entitled ‘Clinical Pharmacology Review for Primary Health Care Providers,’ is intended to help pri- mary health care providers select more appropriate prescriptions for frequently used drugs based on up-to-date information. We expect that this effort will contribute to improvements in public health and diminish unnecessary drug use. Introduction tion on the H1 receptor.[8] THERAPEU Antihistamines include some of the most frequently prescribed drugs in the primary health care environment for the symp- Generations and Classes tomatic relief of allergic diseases, the common cold, urticaria, Many primary health care providers are well-informed about T and insomnia.[1-5] The importance of antihistamines has been the different ‘generations’ of antihistamines but not about the ICS TU emphasized as the prevalence of target diseases increases.[6,7] different ‘classes’ characterized according to chemical structure. However, the appropriate use, clinical effectiveness, and target [1] This discrepancy seems reasonable because ‘inter-generation’ T populations for prescription of antihistamines are still a matter differences are more prominent than ‘inter-class’ differences.
    [Show full text]
  • FDA Warns That Abuse and Misuse of the Nasal Decongestant Propylhexedrine Causes Serious Harm This Includes Heart and Mental Health Problems Or Death
    FDA warns that abuse and misuse of the nasal decongestant propylhexedrine causes serious harm This includes heart and mental health problems or death 3-25-2021 FDA Drug Safety Communication What safety concern is FDA announcing? The U.S. Food and Drug Administration (FDA) is warning that the abuse and misuse of the over- the-counter (OTC) nasal decongestant propylhexedrine can lead to serious harm such as heart and mental health problems. Some of these complications, which include fast or abnormal heart rhythm, high blood pressure, and paranoia, can lead to hospitalization, disability, or death. Reports of individuals abusing and misusing propylhexedrine have increased in recent years. Propylhexedrine is safe and effective when used as directed. What is FDA doing? We are requesting that all manufacturers of OTC propylhexedrine nasal decongestant inhalers consider product design changes that support its safe use. For example, modifying the product to create a physical barrier that would make tampering with the device and abusing the propylhexedrine inside more difficult. In addition, decreasing the amount of medicine the device contains could also reduce the risk of serious side effects if abused or misused. We continue to evaluate this safety issue and will determine if additional FDA actions are needed. What is propylhexedrine and how can it help me? Propylhexedrine is a nasal decongestant that is available OTC in an inhaler. It is used short term to temporarily relieve nasal congestion due to colds, hay fever, or other upper respiratory allergies. It works by reducing swelling and inflammation of the mucous membrane lining of the nose.
    [Show full text]
  • Modified Release
    Product list Modified Release Our product list consist of the pharmaceuticals, pharmaceutical associations and food in the dosages and forms most required by our customers (please check www.osmopharm.com for more details). Our Research and Development competencies are assuring the flexibility in developing new formulations and forms of the products in list as well as new ones. PRODUCTS RELEASE BULK FORM DOSAGE FINAL FORM THERAPEUTICITY A Acetazolamide SR Pellets 500 mg caps Diuretic Alfacalcidol IR Pellets 1 μg caps Vit D supplement Alfuzosin Hydrochloride SR Powder 2.5 mg – 10 mg tabs Prostatic Hypertrophy agent Allopurinol SR Pellets 300 mg caps Antiurolytic Alprazolam SR Pellets 1 mg caps Anxiolytic Ambroxol HCI SR Pellets 75 mg, 120 mg caps Expectorant Ambroxol HCI SR Resinates 75 mg, 120 mg caps / tabs Expectorant Amitriptyline SR Pellets 25 mg, 50 mg, 75 mg caps Antidepressant Aspirin EC, IR Pellets 100 mg caps Anticoagulant Aspirin EC, IR Microcapsules 100 mg caps / tabs Anticoagulant Atenolol IR Pellets 50 mg caps Antihypertensive Azithromycin IR Pellets 250 mg caps Antibiotic B B-complex Benproperine IR Resinates 25 mg, 50 mg caps / tabs Antitussive Betahistine 2HCI SR Pellets 12 mg, 24 mg, 48 mg caps Vasodilator Bromopride* SR Pellets 20 mg caps Antiemetic Brompheniramine maleate SR Pellets 6 mg, 8 mg, 12 mg caps Antihistaminic C Caffeine SR, IR Pellets 25 mg, 50 mg, 300 mg caps CNS Stimulant Carbetapentane citrate SR Pellets 75 mg caps Antitussive Carbinoxamine maleate SR Pellets 4mg, 6 mg caps Antihistaminic Carbinoxamine
    [Show full text]
  • Sudafed Decongestant Tablets 12S PIL SNAS 3359 SNAS 3557 14 Mm 29.07.2021 English Rate and Blood Pressure)
    12 mm 12 mm spot = 12 x 2 centered in Distance between cutted the margin of 14 mm line/middel of the spot = 51.6 mm UK_Sudafed Decongestant Tablets 12s_PIL_SNAS 3359_SNAS 3557 14 mm 29.07.2021 English rate and blood pressure). 402059927_r2 N/A Now read this whole leaflet carefully before you use this medicine. Keep the leaflet: you ■ If you have an overactive thyroid Brochure/Leaet/Insert 145 x 250 mm might need it again. gland. 360165B BL-Val de Reuil_France ■ If you have glaucoma (increased CHILD 360165A Multi Packaging Solutions St Pierre 1 What the medicine is for pressure in the eye). 953 Oset Printing Sudafed Decongestant Tablets is a medicine used ■ If you have severe kidney problems. 8169503 PAPER to provide relief from cold, flu and allergy ■ If you are taking beta blockers (used to EMEA_2020_00006767_001 PC-0002778 symptoms such as blocked sinuses, stuffy nose treat high blood pressure). and catarrh. ■ If you are taking, or have taken in the The tablets contain pseudoephedrine last two weeks, drugs for depression ■ This medicine is used to help clear cold, flu hydrochloride, which is a decongestant that known as Monoamine Oxidase and allergy symptoms such as blocked relieves nasal and sinus congestion. Inhibitors (MAOIs) or Reversible Black PANTONE sinuses, stuffy nose and catarrh. This medicine is for use by adults and children Inhibitors of Monoamine Oxidase 3005 C ■ This medicine is for use by adults and (RIMAs). LITHO OFFSET LITHO OFFSET aged 12 years and over. children aged 12 years and over. 145 mm REPRESENTATION: Colours represented with a diagonal line have been modified to aid PDF approval.
    [Show full text]
  • Histamine and Antihistamines Sites of Action Conditions Which Cause Release Aron H
    Learning Objectives I Histamine Pharmacological effects Histamine and Antihistamines Sites of action Conditions which cause release Aron H. Lichtman, Ph.D. Diagnostic uses Associate Professor II Antihistamines acting at the H1 and H2 receptor Pharmacology and Toxicology Pharmacological effects Mechanisms of action Therapeutic uses Side effects and drug interactions Be familiar with the existence of the H3 receptor III Be able to describe the main mechanism of action of cromolyn sodium and its clinical uses Histamine Pharmacology First autacoid to be discovered. (Greek: autos=self; Histamine Formation akos=cure) Synthesized in 1907 Synthesized in mammalian tissues by Demonstrated to be a natural constituent of decarboxylation of the amino acid l-histidine mammalian tissues (1927) Involved in inflammatory and anaphylactic reactions. Local application causes swelling redness, and edema, mimicking a mild inflammatory reaction. Large systemic doses leads to profound vascular changes similar to those seen after shock or anaphylactic origin Histamine Stored in complex with: Heparin Chondroitin Sulfate Eosinophilic Chemotactic Factor Neutrophilic Chemotactic Factor Proteases 1 Conditions That Release Histamine 1. Tissue injury: Any physical or chemical agent that injures tissue, skin or mucosa are particularly sensitive to injury and will cause the immediate release of histamine from mast cells. 2. Allergic reactions: exposure of an antigen to a previously sensitized (exposed) subject can immediately trigger allergic reactions. If sensitized by IgE antibodies attached to their surface membranes will degranulate when exposed to the appropriate antigen and release histamine, ATP and other mediators. 3. Drugs and other foreign compounds: morphine, dextran, antimalarial drugs, dyes, antibiotic bases, alkaloids, amides, quaternary ammonium compounds, enzymes (phospholipase C).
    [Show full text]
  • Mucolytic Agents & Decongestants
    Mucolytic Agents & Decongestants Mucolytic agents (Guaifenesin Mucinex® Humibid LA®) are drugs that thin mucus and secretions, so they can drain out of the sinuses more easily. They may be helpful for people suffering from a thick post-nasal drip. Often, they are found in combination preparations with decongestants and/or antihistamines. Most are well tolerated and have few side effects such as headache, rash, or nausea. Topical Nasal Decongestants Topical nasal decongestants (Afrin® or Neosynephrine®) in the form of drops or sprays that are placed in the nose can be very effective in shrinking nasal swelling in minutes. However, these sprays should be used no longer than 2 or 3 consecutive days, for prolonged usage may result in "rebound" swelling of the nose. Rebound swelling (known as "rhinitis medicamentosa") can be extremely difficult to treat because the nose may no longer respond normally to the decongestant spray. We advise that use the brands that contain oxymetazoline in preference to those that have phenylephrine as their active ingredient. The safe use of these medications sometimes can be extended by using the medicine only at bedtime, in alternating nostrils every other night. For example, on the first night only the right nostril receives medicine and on the second night the medicine is placed in your left nostril. By doing this some patients can double the safe use of oxymetazoline. Systemic Decongestants If more prolonged decongestant therapy is required, systemic decongestants may be used. The most well know brand is Sudafed®. It comes in varying strengths and is purchased over the counter. Psuedoephedrine can befound as part of a combination medication with some antihistamines such as Allegra® or Claritin®.
    [Show full text]
  • Adverse Cardiac Effects of Decongestant Agents
    Review Eur J Gen Med 2013; 10 (Suppl 1):32-35 Adverse Cardiac Effects Of Decongestant Agents Zeynettin Kaya, Abdullah Tuncez ABSTRACT Especially in spring and winter months many people use excessive dose topical or systemic decongestant agents to relief the al- lergic or infectious nasal congestive symptoms without physicians’ prescription. Although these agents bring some symptomatic benefits, sometimes serious adverse cardiac events reported at all drug users, especially who had known cardiac disease. These agents may cause slightly elevation of blood pressure in hypertensive patients, can trigger mortal arrhythmias like ventricular tachycardia, can also trigger myocardial infarction patients with known coronary artery disease or normal coronary artery and may cause decompensation of heart failure. In conclusion all these decongestant agents give only symptomatic relief and they don’t treat flu and allergic disease. For this reason if the symptoms are mild or moderate not using these agents will be more wisely. Key words: Decongestants, pseudoephedrine, phenylephrine, cardiac, arrhythmias Dekonjestan Ajanların Kardiyak Yan Etkileri ÖZET Özellikle bahar ve kış aylarında insanların birçoğu allerjik ya da enfeksiyona bağlı nasal konjesyonu gidermek için gereğinden fazla ve sıklıkla reçetesiz topikal veya sistemik dekonjestanları kullanmaktadırlar. Bu ilaçların semptomatik faydalarına karşın özellikle bilinen kardiyak hastalığı olanlar başta olmak üzere tüm kullanan kişilerde ciddi istenmeyen kardiyak olaylara neden olabildiği bildirilmiştir. Hipertansif hastalarda az da olsa kan basıncını yükselttiği, bazıları ventriküler taşikardi gibi ölümcül ola- bilen pek çok aritmiyi tetiklediği, bilinen koroner arter hastalığı olan ya da normal koroner anatomiye sahip kişilerde miyokard enfarktüsünü tetikleyebildiği, kalp yetmezliği olan hastalarda dekompansasyona neden olabildiği rapor edilmiştir. Sonuç olarak tüm dekonjestan ajanların allerjiyi, soğuk algınlığını tedavi etmediği sadece semptomatik rahatlama sağladığı unutulmamalıdır.
    [Show full text]
  • Beechams Cold and Flu Capsules
    • if you are taking tricyclic antidepressants V6 (e.g. imipramine or amitriptyline) or if you 04 - FEB - 2021 are taking or have taken within the last two weeks monoamine oxidase inhibitors (MAOIs) (e.g. moclobemide) prescribed for Artwork Information Panel depression D2A SGS No: COLD & FLU • if you are taking beta blockers (e.g. atenolol). 6069879 CAPSULES Do not take anything else containing Non Production Paracetamol, Phenylephrine, paracetamol while taking this medicine. CHAMPS No: Caffeine Do not take with any other flu, cold or Production X 0000001485 decongestant products. Manufacturing Site: Site Component No: Please read right through this leaflet before Take special care with Beechams Alcala 62000000051687 you start using this medicine. This medicine Cold & Flu Capsules is available without prescription, but you still • Contains paracetamol. Taking too much Market: Site Change Control No:Approving need to use Beechams Cold & Flu Capsules paracetamol can cause serious harm to Great Britain N/A carefully to get the best results from it. your liver. Product Market Trade Name: Component Type: • Keep this leaflet you may need to read it again. • This product may cause dizziness. If affected BEECHAMS_COLD & FLU Leaflet • If you have any questions, or if there is do not drive or operate machinery. anything you do not understand, ask your Technical Drawing No: Material Spec No: pharmacist. Ask your doctor before you L607D008 N/A take this medicine: In this leaflet: Print Process: Pharma Code No: • if you have a blood vessel disease such as Offset - Lithography 2339 1. What Beechams Cold & Flu Capsules do Raynaud’s Phenomenon 2.
    [Show full text]
  • UQ272429 OA.Pdf
    Cochrane Database of Systematic Reviews Oral antihistamine-decongestant-analgesic combinations for the common cold (Review) De Sutter AIM, van Driel ML, Kumar AA, Lesslar O, Skrt A De Sutter AIM, van Driel ML, Kumar AA, Lesslar O, Skrt A. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD004976. DOI: 10.1002/14651858.CD004976.pub3. www.cochranelibrary.com Oral antihistamine-decongestant-analgesic combinations for the common cold (Review) Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 BACKGROUND .................................... 3 OBJECTIVES ..................................... 3 METHODS ...................................... 4 RESULTS....................................... 5 Figure1. ..................................... 7 Figure2. ..................................... 8 DISCUSSION ..................................... 19 AUTHORS’CONCLUSIONS . 20 ACKNOWLEDGEMENTS . 20 REFERENCES ..................................... 21 CHARACTERISTICSOFSTUDIES . 24 DATAANDANALYSES. 64 Analysis 1.1. Comparison 1 Combination 1: Antihistamine-decongestant, Outcome 1 Global evaluation. 66 Analysis 1.2. Comparison 1 Combination 1: Antihistamine-decongestant, Outcome 2 Side effects: all - Combination 1: Antihistamine-decongestant. 67 Analysis 1.3. Comparison 1 Combination 1: Antihistamine-decongestant,
    [Show full text]
  • Reference 5 Common Prescription Medications
    M Health Fairview EMS Medical Operations Manual Reference 5 Common Prescription Medications NAME CLASSIFICATION & USE Generic Name Brand Drug Category Pharmacologic Class Name Acetaminophen Tylenol Analgesics/Anti- Non-Steroidal Anti- inflammatory inflammatory/Analgesic/Antipyretic Acyclovir Zovirax Antimicrobial Antiviral Albuterol Ventolin Respiratory Brochodilator Alendronate Fosamax Renal/Electrolyte Bisphosphonate Allopurinol Zyloprim Analgesics/Anti- Gout Therapy inflammatory Alprazolam Xanax Central Nervous Anxiolytics/Sedatives/Hypnotics System Amiodarone Cordarone Cardiovascular Antiarrhythmic Amitriptyline Elavil Central Nervous Antidepressant System Amlodipine Norvasc Cardiovascular Antihypertensive Amlodipine/Atorvastatin Caduet Cardiovascular Antihypertensive/Hypolipemic Amlodipine/Benazepril Lotrel Cardiovascular Antihypertensive Amoxicillin Amoxil Antimicrobial Antibiotic Amoxicillin/Clavulanate Augmentin Antimicrobial Antibiotic Amphetamine/Dextroamphetamine Adderall XR Central Nervous Stimulant System Aripiprazole Abilify Central Nervous Antipsychotic System Aspirin Bayer Analgesics/Anti- Non-Steroidal Anti- Aspirin inflammatory inflammatory/Anti-platelet Atenolol Tenormin Cardiovascular Antihypertensive Atorvastatin Lipitor Cardiovascular Hypolipemic Atropine Atropen Autonomic Antimuscarinic Azithromycin Zithromax Antimicrobial Antibiotic Beclomethasone Qvar Respiratory Topical Corticosteroid Benazepril Lotensin Cardiovascular Antihypertensive Bismuth Subsalicylate Pepto Gastrointestinal Acid/Peptic/Gastric Anti- Bismol
    [Show full text]
  • The Effect of Pseudoephedrine on Blood Pressure in Patients With
    The Effect Of Pseudoephedrine On Blood Pressure J Am Board Fam Pract: first published as 10.3122/jabfm.4.4.201 on 1 July 1991. Downloaded from In Patients With Controlled, Uncomplicated Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial John G. Bradley, M.D., Ken]. Kallai~ Ph.D., John N. Dorsch, M.D., andJoan Fox, R.N. Abslrtlet: Pseudoephedrine is frequendy used as a decongestant. Because of concern about 1be safety of pseudoephedrine in hypertensive patients, a clinical1rial was conducted to detennine whether blood pressure control was actuallya1fected by 1bis drug in a selected group of patients with hypertension. 1Wenty-nine patients wi1b controlled, uncomplicated hypertension, who received drug therapy and ranged in age from 25 to 50 years, were randomized to a treatment or a control group. Subjects took eI1ber 60 mg of pseudoephedrine or placebo capsules four times a day for 3 days. From 0800 hours until 2200 hours each day, the subjects obtained hourly blood pressure measurements using a porlable sphygmomanometer. An analysis of variance wi1b repeated measures was calculated to determine group differences for systolic and diastoUc readings. No statistically or clinically signiftcant differences were found. 1berapeu1ic: doses of pseudoephedrine did not adversely affect control of hypertension in 1bese selected patients. 0 Am Board Fam Pract 1991; 4:201-6.) Pseudoephedrine, phenylpropanolamine, and in hypertensive patients. While no adverse effect phenylephrine are oral sympathomimetic agents was found,IO this study was uncontrolled, a com­ commonly used as decongestants in prescription bination of drugs was used, and patient compli­ and over-the-counter preparations. Long-stand­ ance was unverified.
    [Show full text]
  • Side Effects of Some Commonly Used Allergy Medications (Decongestants, Anti-Leukotriene Agents, Antihistamines, Steroids, and Zinc) and Their Safety in Pregnancy
    ISSN: 2572-3308 Malone and Kennedy. Int J Aller Medications 2017, 3:024 DOI: 10.23937/2572-3308.1510024 Volume 3 | Issue 1 International Journal of Open Access Allergy Medications REVIEW ARTICLE Review: Side Effects of Some Commonly Used Allergy Medica- tions (Decongestants, Anti-Leukotriene Agents, Antihistamines, Steroids, and Zinc) and Their Safety in Pregnancy Michael Malone1* and Tara M Kennedy2 1Associate Professor and Medical Director, Department of Family and Community Medicine, Pennsylvania State University, USA 2Resident Physician, Department of Family and Community Medicine, Pennsylvania State University, USA *Corresponding author: Michael Malone, Associate Professor and Medical Director, Department of Family and Community Medicine, Pennsylvania State University, USA, E-mail: [email protected] Abstract Introduction Objective: The aim of this study was to evaluate the safety Allergic conditions are common, although most indi- and side-effects of common allergy medications. viduals with allergies do not seek medical care [1]. In the Methodology: A literature search was undertaken. We searched United States allergy medications are readily available the databases of Pubmed, MEDLINE, EMBASE databases, and over the counter. While most people will report relief of Cochrane Library from 1990 to October 2016, using key words: their symptoms with readily available allergy treatments, Allergy, Medications, Antihistamines, Decongestants, Montelu- approximately 7% of patients who take these medications kast, Side effects, Adverse Events, Adverse, Effects, Zinc, Ste- roids, Pregnancy, Reviews, RCT, and Case Report. will experience adverse effects (AEs), which can be severe [2]. This article will review side effects reported in the lit- Results: Antihistamines can cause undesired anti-cholinergic erature for some of the most common prescription and effects including mydraisais, sedation, dry eyes, dry mouth, con- stipation and urinary retention.
    [Show full text]